Market accessOfficial
ANSM issues new accreditation rules for external quality control bodies, repealing 2019 order
🇫🇷 ANSM · Mon 16 Nov 2026
A decision dated 13 November 2026 sets accreditation arrangements for external quality control organisations and will end the 2019 order on the same subject after 18 months.
France's medicines and health products agency, ANSM, has published a decision setting the arrangements under which organisations carrying out external quality control (external quality assessment) are accredited. The decision is dated 13 November 2026 and was published on 16 November 2026.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Article written by VigiEye from the official source (ANSM). AI-assisted; check the source before acting.
More Market access
All →
China adds Ascentage's lisaftoclax to NRDL; olverembatinib coverage renewed after renegotiation
Ascentage Pharma Group International (AAPG) · Mon 16 Nov 2026
INFARMED updates Portugal's reference price groups for fourth quarter of 2026
🇵🇹 INFARMED · Mon 16 Nov 2026
AIFA updates Italy's Transparency Lists of generics and reference prices as of 16 November
🇮🇹 AIFA · Mon 16 Nov 2026
AIFA publishes updated transparency lists with generic reference prices as of 16 November
🇮🇹 AIFA · Mon 16 Nov 2026
MSD to end Emend (aprepitant) marketing in EU/EEA; Italy's 125 mg + 80 mg capsules go from 30 November
🇮🇹 AIFA · Mon 16 Nov 2026
Estonia's human medicines market grows 11.7% in third quarter of 2026
🇪🇪 Ravimiamet · Mon 16 Nov 2026